Response to "Influence of Diabetes on Antiplatelet Drug Efficacy"

Aleksi Tornio, Colin N. A. Palmer, Alex S. F. Doney (Lead / Corresponding author)

Research output: Contribution to journal › Letter › peer-review

197 Downloads (Pure)

Original language	English
Pages (from-to)	573
Number of pages	1
Journal	Clinical Pharmacology & Therapeutics
Volume	103
Issue number	4
Early online date	22 Feb 2018
DOIs	https://doi.org/10.1002/cpt.1002
Publication status	Published - 1 Apr 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Final Published Version
© 2018 The Authors Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Final published version, 66.6 KBLicence: CC BY-NC

@article{ab1212a155eb40f19157ba78aa472dca,

title = "Response to {"}Influence of Diabetes on Antiplatelet Drug Efficacy{"}",

author = "Aleksi Tornio and Palmer, {Colin N. A.} and Doney, {Alex S. F.}",

note = "The GoDARTS Bioresource has been funded by a wide range of sources of many years. The present study was unfunded.",

year = "2018",

month = apr,

day = "1",

doi = "10.1002/cpt.1002",

language = "English",

volume = "103",

pages = "573",

journal = "Clinical Pharmacology & Therapeutics",

issn = "0009-9236",

publisher = "American Society for Clinical Pharmacology and Therapeutics",

number = "4",

}

TY - JOUR

T1 - Response to "Influence of Diabetes on Antiplatelet Drug Efficacy"

AU - Tornio, Aleksi

AU - Palmer, Colin N. A.

AU - Doney, Alex S. F.

N1 - The GoDARTS Bioresource has been funded by a wide range of sources of many years. The present study was unfunded.

PY - 2018/4/1

Y1 - 2018/4/1

U2 - 10.1002/cpt.1002

DO - 10.1002/cpt.1002

M3 - Letter

C2 - 29468659

VL - 103

SP - 573

JO - Clinical Pharmacology & Therapeutics

JF - Clinical Pharmacology & Therapeutics

SN - 0009-9236

IS - 4

ER -